APP and metabolic syndrome: Our results showed a significant increase in cortical Aβ aggregates in MetS-induced and resistin-treated APP/PSN1 animals compared to controls, while ApN treatment caused a significant reduction in cortical Aβ deposition (Figures 5A, B).